Germany: Sonic Healthcare to acquire Diagnosticum group of laboratories  

ASX-listed Sonic Healthcare is to acquire the Diagnosticum group of laboratories, one of the largest clinical and anatomical pathology laboratory groups operating in Southeast Germany. The purchase price of €190m (US$207m) – cash and debt free – will be funded in euro from Sonic’s existing cash and debt facilities, with the majority of the purchase…

You must be a HMI Subscriber to view this content.

Subscribe Now »